MediPharm Labs Corp. (TSX:LABS)
Canada · Delayed Price · Currency is CAD 0.0750
+0.0050 (7.14%)
Jun 12, 2026, 3:33 PM EST
MediPharm Labs Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 43.28 | 45.12 | 41.96 | 33.06 | 22.12 | 21.71 | |
Revenue Growth (YoY) | 0.66% | 7.54% | 26.92% | 49.49% | 1.87% | -39.71% |
Cost of Revenue | 30.38 | 31.56 | 28.47 | 28.4 | 24.03 | 36.96 |
Gross Profit | 12.9 | 13.56 | 13.49 | 4.67 | -1.91 | -15.25 |
Selling, General & Admin | 21.55 | 21.98 | 23.2 | 23.33 | 25.72 | 31.24 |
Research & Development | 0.17 | 0.22 | 0.24 | 0.21 | 1 | 1.36 |
Other Operating Expenses | -0.18 | -0.21 | 0.86 | -0.62 | 0.9 | 1.07 |
Total Operating Expenses | 21.53 | 22 | 24.3 | 22.92 | 27.62 | 33.67 |
Operating Income | -8.91 | -8.44 | -10.81 | -18.25 | -29.53 | -48.92 |
Interest Income | 0.22 | 0.23 | 0.69 | 0.84 | 0.48 | 0.23 |
Interest Expense | -0.06 | -0.06 | -0.58 | -0.37 | -0.03 | -10.51 |
Other Non-Operating Income (Expense) | - | - | - | 4.42 | -0.9 | 4.51 |
Total Non-Operating Income (Expense) | 0.16 | 0.17 | 0.12 | 4.89 | -0.46 | -5.77 |
Pretax Income | -3.77 | -8.27 | -10.69 | -13.36 | -29.99 | -54.69 |
Provision for Income Taxes | - | - | - | 0.28 | 0.01 | -0.11 |
Net Income | -8.75 | -8.27 | -10.69 | -13.08 | -29.98 | -54.8 |
Net Income to Common | -8.75 | -8.27 | -10.69 | -13.08 | -29.98 | -54.8 |
Shares Outstanding (Basic) | 421 | 418 | 408 | 363 | 277 | 250 |
Shares Outstanding (Diluted) | 421 | 418 | 408 | 363 | 277 | 250 |
Shares Change (YoY) | 2.43% | 2.53% | 12.29% | 31.23% | 10.79% | 80.37% |
EPS (Basic) | -0.02 | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
EPS (Diluted) | -0.02 | -0.02 | -0.03 | -0.04 | -0.11 | -0.22 |
Free Cash Flow | -3.38 | -5.6 | -5.02 | -12.81 | -16.93 | -14 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.04 | -0.06 | -0.06 |
Gross Margin | 29.80% | 30.06% | 32.15% | 14.12% | -8.65% | -70.22% |
Operating Margin | -20.58% | -18.70% | -25.76% | -55.21% | -133.53% | -225.31% |
Profit Margin | -20.21% | -18.32% | -25.49% | -39.57% | -135.56% | -252.41% |
FCF Margin | -7.80% | -12.42% | -11.95% | -38.75% | -76.56% | -64.46% |
EBITDA | -7.29 | -6.78 | -8.21 | -15.74 | -26.66 | -43.28 |
EBITDA Margin | -16.84% | -15.02% | -19.56% | -47.60% | -120.54% | -199.36% |
EBIT | -8.91 | -8.44 | -10.81 | -18.25 | -29.53 | -48.92 |
EBIT Margin | -20.58% | -18.70% | -25.76% | -55.21% | -133.53% | -225.31% |
Effective Tax Rate | - | 0.00% | 0.00% | -2.07% | -0.02% | 0.21% |